Загрузка...
Rosiglitazone alleviates lipopolysaccharide-induced inflammation in RAW264.7 cells via inhibition of NF-κB and in a PPARγ-dependent manner
Rosiglitazone is a synthetic peroxisome proliferator-activated receptor (PPAR)γ agonist widely used for the treatment of type 2 diabetes. Recent studies have demonstrated that rosiglitazone displays anti-inflammatory effects. The present study aimed to investigate whether rosiglitazone alleviates de...
Сохранить в:
| Опубликовано в: : | Exp Ther Med |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8138265/ https://ncbi.nlm.nih.gov/pubmed/34055059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.10175 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|